Alice Kan[email protected]SequencingSequencing seeks to stay ahead of new COVID-19 surgesSequencing has been an essential tool for the development of strategies and therapeutics in the fight against COVID-19, and sequencing-based rapid and high-throughput diagnostics for COVID-19 are in development. Sequencing technology suppliers are collaborating with researchers to develop sequencing-based diagnostic tools. For example, several groups are using Illumina's next-generation sequencing (NGS) technology to develop ultrahigh-throughput COVID-19 diagnostic testing.June 7, 2020PCRVendors struggle to supply RNA extraction kits due to COVID-19SARS-CoV-2, the coronavirus responsible for the COVID-19 illness, encodes its genome in a single-stranded RNA. In vitro diagnostics of COVID-19 are done by quantitative PCR (qPCR), but first RNA must be extracted from a patient sample and reverse transcribed.May 10, 2020Page 1 of 1Top StoriesFDA ClearanceAmgen gets FDA approval for small cell lung cancer therapyAmgen announced on Thursday that the U.S. Food and Drug Administration (FDA) has approved its therapy tarlatamab, to be marketed under the name Imdelltra, for the treatment of extensive-stage small cell lung cancer (ES-SCLC).Artificial IntelligenceBacklog of unresolved medical diagnoses leads to new method for clinical exome reanalysisStockT2 Biosystems to sell $8M in stock in private placementFDA Warning LetterFDA issues warning for Cue Health COVID-19 testsSponsor ContentVisit our Molecular Diagnostics Community